Combined targeting of CCL7 and Flt3L to promote the expansion and infiltration of cDC1s in tumors enhances T-cell activation and anti-PD-1 therapy effectiveness in NSCLC

联合靶向 CCL7 和 Flt3L 可促进肿瘤中 cDC1 的扩增和浸润，从而增强 T 细胞活化和抗 PD-1 疗法在非小细胞肺癌中的疗效。